Previous close | 22.29 |
Open | 22.25 |
Bid | 22.25 x 200 |
Ask | 22.31 x 200 |
Day's range | 22.14 - 22.42 |
52-week range | 14.10 - 26.01 |
Volume | |
Avg. volume | 644,696 |
Market cap | 2.769B |
Beta (5Y monthly) | 0.50 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.25 |
Earnings date | 09 May 2024 - 13 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 26.00 |
UPPSALA, Sweden, April 02, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced the availability of an open access data library consisting of over 300,000 protein-disease risk associations, giving researchers a powerful new tool for revealing the biological mechanisms underlying 106 human diseases. In April 2023, the UK Biobank Pharma Proteomics Project (UKB-PPP) released data produced from over 50,000 samples analyzed using the Olink® Explore platform. The UKB-PPP is t
As you might know, Olink Holding AB (publ) ( NASDAQ:OLK ) last week released its latest yearly, and things did not turn...
The analysts covering Olink Holding AB (publ) ( NASDAQ:OLK ) delivered a dose of negativity to shareholders today, by...